Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (1-10 of 775) with videos related to

Pageof 78
Sort By:
Hepatology (Baltimore, Md.)|June 29, 2007
A little orphan runs to fat: the orphan receptor small heterodimer partner as a key player in the regulation of hepatic lipid metabolismMichael Trauner
Journal of Hepatology|August 19, 2020
EASL Recognition Award Recipient 2020: Prof. James L. BoyerMichael Trauner
Gastroenterology|March 4, 2003
When bile ducts say NO: the good, the bad, and the uglyMichael Trauner
Hepatology (Baltimore, Md.)|July 9, 2004
The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: hype or hope?Michael Trauner
Journal of Hepatology|June 3, 2020
Effective medical treatments for PSC needed ASAP - is AESOP the answer?Michael Trauner
Journal of Hepatology|June 12, 2012
EASL recognition awardee 2012: Professor Peter L.M. JansenMichael Trauner
Gastroenterology|February 22, 2011
Nuclear receptors as new perspective for the management of liver diseasesMichael Trauner, Emina Halilbasic
F1000Research|May 3, 2016
Recent advances in understanding and managing cholestasisMartin Wagner, Michael Trauner
Journal of Hepatology|August 10, 2023
FXR agonists in NASH treatmentLuciano Adorini, Michael Trauner
Seminars in Liver Disease|July 21, 2021
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic OpportunitiesRichard Radun, Michael Trauner
Pageof 78

Showing results (1-10 of 775) with videos related to

Sort By:
Pageof 78
Hepatology (Baltimore, Md.)|June 29, 2007
A little orphan runs to fat: the orphan receptor small heterodimer partner as a key player in the regulation of hepatic lipid metabolismMichael Trauner
Journal of Hepatology|August 19, 2020
EASL Recognition Award Recipient 2020: Prof. James L. BoyerMichael Trauner
Gastroenterology|March 4, 2003
When bile ducts say NO: the good, the bad, and the uglyMichael Trauner
Hepatology (Baltimore, Md.)|July 9, 2004
The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: hype or hope?Michael Trauner
Journal of Hepatology|June 3, 2020
Effective medical treatments for PSC needed ASAP - is AESOP the answer?Michael Trauner
Journal of Hepatology|June 12, 2012
EASL recognition awardee 2012: Professor Peter L.M. JansenMichael Trauner
Gastroenterology|February 22, 2011
Nuclear receptors as new perspective for the management of liver diseasesMichael Trauner, Emina Halilbasic
F1000Research|May 3, 2016
Recent advances in understanding and managing cholestasisMartin Wagner, Michael Trauner
Journal of Hepatology|August 10, 2023
FXR agonists in NASH treatmentLuciano Adorini, Michael Trauner
Seminars in Liver Disease|July 21, 2021
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic OpportunitiesRichard Radun, Michael Trauner
Pageof 78